Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel V Kalinovsky

7PUBLICATIONS
9CO-AUTHORS
GlycoconjugatesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Feb 27, 2026
GD2-Targeted Minibody-Drug Conjugates Match the Potency of IgG-Based ADCs in a Mouse Cancer Model.

Daniel V Kalinovsky, Matvey M Titov, Irina V Kholodenko

|Oct 27, 2023
Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.

Daniel V Kalinovsky, Irina V Kholodenko, Elena V Svirshchevskaya

|Jan 21, 2023
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.

Daniel V Kalinovsky, Irina V Kholodenko, Alexey V Kibardin

|Jun 28, 2022
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.

Daniel V Kalinovsky, Alexey V Kibardin, Irina V Kholodenko

|Jun 04, 2020
RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype.

Maxim Sorokin, Irina Kholodenko, Daniel Kalinovsky

|Oct 27, 2019
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies.

Irina V Kholodenko, Daniel V Kalinovsky, Elena V Svirshchevskaya

Pageof 2

Frequent Collaborators

7 joint publications

Roman V Kholodenko

6 joint publications

Irina V Kholodenko

3 joint publications

Sergey S Larin

3 joint publications

Sergey M Deyev

2 joint publications

Mariya V Konovalova

2 joint publications

Elena V Svirshchevskaya

2 joint publications

Dmitry Yu Ryazantsev

1 joint publications

Tatyana Shamanskaya

1 joint publications

Igor I Doronin

Frequent Collaborators

7 joint publications

Roman V Kholodenko

6 joint publications

Irina V Kholodenko

3 joint publications

Sergey S Larin

3 joint publications

Sergey M Deyev

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

4.0K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on : Jan 22, 2018

11.1K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.7K
See more related videos

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

4.0K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on : Jan 22, 2018

11.1K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.7K
See more related videos